House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Ophthalmology

Primary angle-closure disease

AAO · 2026 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

AAO management separates an anatomically narrow angle from established primary angle closure and glaucomatous damage. Gonioscopy defines the anatomy; an acute symptomatic pressure rise requires prompt pressure reduction and relief of pupillary block, while longer-term care addresses residual closure, lens contribution and optic-nerve progression.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Define the stage and mechanism

  • Primary angle-closure suspect means at least 180 degrees of iridotrabecular contact without raised pressure, peripheral anterior synechiae or glaucomatous optic neuropathy. Primary angle closure adds raised pressure and/or synechiae; primary angle-closure glaucoma additionally has glaucomatous nerve damage. [1]
  • Use dark-room dynamic gonioscopy to diagnose disease and reassess the angle after treatment. Examine both eyes; indentation helps distinguish reversible apposition from synechial closure. Anterior-segment OCT and ultrasound complement gonioscopy, with ultrasound more reliable for plateau iris. [1]
  • Review intermittent symptoms, family history and medications that can provoke pupillary block or cause ciliary-body oedema, including topiramate. A wide-open fellow-eye angle suggests an alternative to primary disease; secondary mechanisms need separate assessment. [1]
  • Measure pressure in both eyes and assess the optic nerve. Where iridotomy is indicated, dilated retinal and nerve examination can usually wait until after the procedure; dilation of an untreated narrow angle requires counselling about the possibility and symptoms of a crisis. [1]

Individualize prevention in suspects

  • For a primary angle-closure suspect, consider laser peripheral iridotomy to reduce progression or acute-crisis risk. Observation for rising pressure, progressive narrowing or synechiae is an alternative; discuss postoperative visual disturbances and other procedural harms. [1]
  • Factors favouring prophylactic iridotomy include disease in the fellow eye, a family history of glaucoma from angle closure, intermittent symptoms, provoking medicines, frequent dilation, or difficulty accessing urgent care or completing follow-up. [1]
  • Untreated suspects should understand acute-crisis symptoms and seek immediate ophthalmic care if they occur. Discuss medicines with anticholinergic effects that may dilate the pupil; successful iridotomy does not eliminate the need for pressure surveillance. [1]

Treat an acute attack and protect the fellow eye

  • Suspect an acute crisis with eye pain, headache, nausea or vomiting and blurred vision with halos, especially with markedly raised pressure, corneal oedema, vascular congestion or a mid-dilated pupil. Untreated attacks can rapidly cause permanent visual loss. [1]
  • Start prompt pressure-lowering treatment to relieve pain, clear corneal oedema and protect the optic nerve. Medical therapy is usually first, followed by laser peripheral iridotomy as soon as safely feasible to bypass pupillary block. [1]
  • Markedly elevated pressure may make the pupil unresponsive to miotics through sphincter ischaemia. Systemic hyperosmotic treatment may be required. Drug choice depends on mechanism; secondary block is not automatically managed with the same pupil-constricting approach. [1]
  • If the iris cannot be visualized or the attack cannot be broken medically, specialist alternatives include iridoplasty, anterior-chamber paracentesis or incisional iridectomy. Definitive relief of pupillary block remains necessary when feasible. [1]
  • Early lens extraction after initial medical pressure reduction may improve ongoing control, but comparative evidence after an acute attack is limited and operative risk is higher in crowded, especially unbroken, eyes. [1]
  • Evaluate the fellow eye promptly and schedule prophylactic iridotomy if its angle is anatomically narrow. Attacks can occur within days. Chronic parasympathomimetic treatment is not an appropriate substitute for fellow-eye iridotomy. [1]

Address residual disease and the lens

  • Lens extraction is an effective option for established angle-closure glaucoma or primary angle closure with markedly raised pressure, even without visually significant cataract. Consider the risks and benefits of the available procedures for the individual patient. [1]
  • Adding goniosynechiolysis to cataract surgery may reduce medication burden and synechiae, but additional pressure benefit is uncertain. Evidence for combined minimally invasive glaucoma procedures in these eyes remains limited by small studies and short follow-up. [1]
  • Plateau iris with recurrent raised pressure and a closed angle despite patent iridotomy requires further treatment. Iridoplasty, medication or surgery may be considered; lens extraction alone does not guarantee prevention of another attack. Evidence does not support routine prophylactic iridoplasty for every plateau-iris eye. [1]

Verify patency and monitor lifelong risk

  • After iridotomy, directly confirm patency rather than relying on a red reflex. Check pressure immediately before and within 30 minutes to 2 hours after laser treatment, prescribe postoperative topical steroid therapy, and arrange adequate postoperative care. [1]
  • In the days and weeks after treatment, reassess patency, pressure, dark-room indentation gonioscopy and the fundus as indicated. Persistent pressure elevation may reflect trabecular damage, synechiae, an occluded iridotomy or a mechanism other than pupillary block. [1]
  • Continue serial gonioscopy, retinal nerve-fibre and macular ganglion-cell imaging, and visual fields to detect new closure or glaucoma progression. Individualize intervals; persistent pressure elevation may require chronic medication or further surgery even after pupillary block has been relieved. [1]

Limitations and use

  • This summary concerns primary angle-closure disease and selected management recommendations. It is not a complete emergency drug-dose algorithm or a procedural manual; secondary drug-induced and other non-pupillary-block mechanisms require distinct treatment decisions.
  • Risk reductions in prophylactic-iridotomy trials and lens-extraction results depend on the studied populations and disease stage. They must not be generalized into routine surgery for every narrow angle.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Primary angle-closure disease

    Selected recommendation material consulted

Preferred Practice Pattern guideline

Publication details

Issuing organisation
AAO
First published
9 February 2026
Resource type
Preferred Practice Pattern guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Define the stage and mechanism
  • Individualize prevention in suspects
  • Treat an acute attack and protect the fellow eye
  • Address residual disease and the lens
  • Verify patency and monitor lifelong risk
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House